Prostamax (20 mg Vial) Dosage Protocol
Quickstart Highlights
Prostamax is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Pro / KEDP) derived from prostate tissue peptide complex research[1][2]. Short peptides of this class have been studied for their ability to modulate gene expression through epigenetic interactions with chromatin and histones[3][4]. This educational protocol presents a once‑daily intramuscular approach using a practical dilution for clear insulin‑syringe measurements.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (2 mL = 10 mg/mL)
Route: Intramuscular (IM) injection once daily[1][2]
| Phase / Week | Daily Dose (mcg / mg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 500 mcg (0.5 mg) | 5 units (0.05 mL) |
| Weeks 3–4 | 750 mcg (0.75 mg) | 7.5 units (0.075 mL) |
| Weeks 5–8 | 1,000 mcg (1 mg) | 10 units (0.10 mL) |
| Weeks 9–12 (optional extension) | 1,000 mcg (1 mg) | 10 units (0.10 mL) |
Frequency: Inject once daily intramuscularly. Preclinical studies used daily IM administration for 15–60 days[1][2]. For administrations ≤10 units (≤0.10 mL), consider 30‑ or 50‑unit insulin syringes for improved readability.
Reconstitution Steps
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
- 8 weeks ≈ 2 vials (~40 mg total at ~0.7 mg/day average)
- 12 weeks ≈ 3 vials (~60 mg total)
- 16 weeks ≈ 4 vials (~80 mg total at ~1 mg/day maintenance)
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- 8 weeks (2 vials): 4 mL → 1 × 10 mL bottle
- 12 weeks (3 vials): 6 mL → 1 × 10 mL bottle
- 16 weeks (4 vials): 8 mL → 1 × 10 mL bottle
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
- 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
- 16 weeks: 224 swabs → recommend 3 × 100‑count boxes
Protocol Overview
Concise summary of the once‑daily regimen.